Equity Details
Price & Market Data
Price: $50.00
Daily Change: +$4.50 / 9.00%
Daily Range: $50.00 - $50.00
Market Cap: $1,650,328,192
Daily Volume: 200
Performance Metrics
1 Week: 17.87%
1 Month: 17.87%
3 Months: 28.21%
6 Months: 45.99%
1 Year: 45.99%
YTD: 26.90%
About (PLYGF)
Up-to-date insights on undefined (PLYGF). Current price: 50.00, daily change: +$4.50 / 9.00%. Market cap: 1,650,328,192. Performance from 1-month to 1-year.
Company Details
Employees: 1469
Sector: Health technology
Industry: Biotechnology
Country: Switzerland
Details
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and analytical services. The company serves academic, pharmaceutical, and biotech companies. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.